Driving change
Gilead Sciences’ Alex Kalomparis says pharma has a role to play in supporting social change and must not shy away from it
Read More
Search Results for: Alex Kalomparis
October 2019
More patients than ever before consider clinical research as a legitimate care option, and, despite the threat of an uncertain Brexit, the UK continues to be viewed as one of the best countries in the world to carry out...
Read More- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
